Forfatter
Tittel Benzodiazepine and z-hypnotic use in Norwegian elderly, aged 65-79
Medansvarlig
Språk
Eier
Emne
Serie
Serienummer 2012, årg.22, nr.2, s.203-208
År
Noter Purpose: Benzodiazepines/z-hypnotics (BZD-Z) guidelines suggest that elderly people ought to use anxiolytic benzodiazepines (BZD) and z-hypnotics only at low dose and only for a short time, and that hypnotic BZD not should be used at all. Since the elderly aged 65-79 tend to be recently retired but still in relatively good health, they may have different needs for BZD-Z than those older or younger. Our objective is to examine BZD-Z use in this age group. Methods: The study population consisted of Norwegians, aged 65-79, who filled prescriptions for anxiolytic BZD, hypnotic BZD and/or z-hypnotics in 2004-2009. The quantities prescribed were in daily defined doses (DDD), and 100 DDD/year was deemed excessive. Results: More than a quarter of the population received at least one BZD-Z prescription each year. Half of those received more than 100 DDD/year and a quarter received over 250 DDD/year, with these proportions increasing year by year. All three subgroups of BZD-Z showed increasing use with age and all except anxiolytic BZD showed increasing proportions of users using more than 100 DDD/year with age. Conclusions: Substantial numbers of elderly aged 65-79 receive prescriptions for BZD-Z, more with increasing age, and greater amounts per user. Guidelines are clearly ignored. While a rigid enforcement of guidelines/rules is not the answer, allowing the status quo to continue shows lack of respect for guidelines.
Tilgjengelige
L�nere p� venteliste
*000 ap
*00134881
*100 $aNeutel, Ineke
*245 $aBenzodiazepine and z-hypnotic use in Norwegian elderly, aged 65-79$cIneke Neutel, Svetlana Skurtveit, Christian Berg
*260 $bNorsk forening for epidemiologi $c2012
*300 $a6 s.
*440 $aNorsk Epidemiologi $v2012, årg.22, nr.2, s.203-208
*520 $aPurpose: Benzodiazepines/z-hypnotics (BZD-Z) guidelines suggest that elderly people ought to use anxiolytic benzodiazepines (BZD) and z-hypnotics only at low dose and only for a short time, and that hypnotic BZD not should be used at all. Since the elderly aged 65-79 tend to be recently retired but still in relatively good health, they may have different needs for BZD-Z than those older or younger. Our objective is to examine BZD-Z use in this age group. Methods: The study population consisted of Norwegians, aged 65-79, who filled prescriptions for anxiolytic BZD, hypnotic BZD and/or z-hypnotics in 2004-2009. The quantities prescribed were in daily defined doses (DDD), and 100 DDD/year was deemed excessive. Results: More than a quarter of the population received at least one BZD-Z prescription each year. Half of those received more than 100 DDD/year and a quarter received over 250 DDD/year, with these proportions increasing year by year. All three subgroups of BZD-Z showed increasing use with age and all except anxiolytic BZD showed increasing proportions of users using more than 100 DDD/year with age. Conclusions: Substantial numbers of elderly aged 65-79 receive prescriptions for BZD-Z, more with increasing age, and greater amounts per user. Guidelines are clearly ignored. While a rigid enforcement of guidelines/rules is not the answer, allowing the status quo to continue shows lack of respect for guidelines.
*650 $aEldre
*650 $aMedikamenter
*651 $aNorge
*700 2$aSkurtveit, Svetlana
*700 2$aBerg, Christian
*7600 $tNorsk Epidemiologi $w34866$x0803-2491
*773 $aNorsk Epidemiologi $gforskningsartikkel
*850 $aALDHELS
*856 $uhttp://www.ntnu.no/ojs/index.php/norepid/article/view/1567
^
Det finnes ingen anmeldelser for denne boken.
Klikk her
for bli den første til å gi din mening